89BIO INC. - COMMON STOCK
8.6300
17-May-24 14:59:59
15 minutes delayed
Stocks
-0.3400
-3.79%
Today's range
8.5900 - 9.0600
ISIN
N/A
Source
NASDAQ
-
89bio to Participate in the SVB Securities Global Biopharma Conference
08 Feb 2023 07:00:02 By Nasdaq GlobeNewswire
-
89bio Provides Business Update and Outlook for 2023
04 Jan 2023 15:01:00 By Nasdaq GlobeNewswire
-
12 Dec 2022 17:30:00 By Nasdaq GlobeNewswire
-
89bio Reports Third Quarter 2022 Financial Results and Provides Corporate Update
10 Nov 2022 15:05:01 By Nasdaq GlobeNewswire
-
05 Nov 2022 12:00:00 By Nasdaq GlobeNewswire
-
89bio to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
13 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
89bio to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
07 Sep 2022 07:00:03 By Nasdaq GlobeNewswire
-
26 Aug 2022 05:00:00 By Nasdaq GlobeNewswire
-
18 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
89bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update
11 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
05 Jul 2022 07:00:01 By Nasdaq GlobeNewswire
-
29 Jun 2022 00:47:09 By Nasdaq GlobeNewswire
-
28 Jun 2022 15:02:00 By Nasdaq GlobeNewswire
-
28 Jun 2022 15:01:00 By Nasdaq GlobeNewswire
-
89bio to Present Additional Pegozafermin Data at EASL International Liver Congress™ 2022
21 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
89bio Reports First Quarter 2022 Financial Results and Provides Corporate Update
11 May 2022 15:05:00 By Nasdaq GlobeNewswire
-
89bio to Participate in Upcoming Investor Conferences
03 May 2022 07:00:02 By Nasdaq GlobeNewswire
-
89bio to Host Key Opinion Leader Webinar on Severe Hypertriglyceridemia (SHTG)
26 Apr 2022 07:00:02 By Nasdaq GlobeNewswire